Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial

• Christine Rotonda,

  Affiliations National Quality of Life in Oncology Platform, Nancy, France, INSERM, CIC-EC CIE6, Nancy, France, CHU Nancy, Clinical Epidemiology and Evaluation Department, Nancy, France

  ⨯
• Amélie Anota ,

  * E-mail: aanota@chu-besancon.fr

  Affiliations National Quality of Life in Oncology Platform, Nancy, France, Université de Franche-Comté, EA 3181, Besançon, France, CHU Besançon, Methodological and quality of life unit in oncology, Besançon, France

  ⨯
• Mariette Mercier,

  Affiliations National Quality of Life in Oncology Platform, Nancy, France, Université de Franche-Comté, EA 3181, Besançon, France

  ⨯
• Bérangère Bastien,

  Affiliation Transgene SA, Illkirch, France

  ⨯
• Gisèle Lacoste,

  Affiliation Transgene SA, Illkirch, France

  ⨯
• Jean-Marc Limacher,

  Affiliation Transgene SA, Illkirch, France

  ⨯
• Elisabeth Quoix,

  Affiliation Hôpitaux Universitaires de Strasbourg, Strasbourg, France

  ⨯
• Franck Bonnetain

  Affiliations National Quality of Life in Oncology Platform, Nancy, France, Université de Franche-Comté, EA 3181, Besançon, France, CHU Besançon, Methodological and quality of life unit in oncology, Besançon, France

  ⨯